Sigma-Aldrich
Life Science

Antibodies
Automation
Cancer Research
Cell Culture
Cell Signaling and Neuroscience
Product Lines
Product Highlights
New Literature
Ion Channels
Key Resources
Cell Signaling Web Tools
New Products
PathFinder
Pathway Slides & Charts
Pharm. Action Table
Poster Gallery
Protocols
Search Tools
eHandbook
Custom Synthesis
Drug Discovery
Epigenetics
Functional Genomics and RNAi
Metabolomics
Molecular Biology
Neuroscience
Nutrition Research
Obesity Research
Peptides and Proteins
Plant Biotechnology
Proteomics and Protein Expr.
Stable Isotopes
Stem Cell Biology
Your Favorite Gene - Search
Life Science Innovations
PathFinder

 

IGF Regulation of Apoptosis

Top Border
Left Border  Right Border
Left Corner Back Download Forward Sigma-Aldrich Right Corner

IGF Regulation of Apoptosis

Model of IGF-I Receptor regulation of apoptosis. Ligand binding to IGF-IR activates the tyrosine kinase domain which initiates a set of signaling cascades. This leads to a higher concentration of the anti-apoptotic proteins bcl-2 and bcl-xL a lower level of the apoptotic proteins bax and bcl-xs. IGF-IR signaling also activates phosphatidylinositol 3-kinase (P13-K), which in turn activates protein kinase B (PKB/Akt) that also prevent apoptosis. These pathways converge on the inhibition of caspases, especially caspase-3, which is then blocked from performing an apoptosis-initiating cleavage of poly(adenosine diphosphate ribose) polymerase (PARP) and blocked from degrading β-catenin, part of the cadherin cell-adhesion system. Thus, IGF stimulates IGF-IR to lower the probability of apoptosis initiation and to retain cell-to-cell junctions.

Back to Top